This week, we speak with Todd Harrison, founder and portfolio manager of CB1 Capital. CB1 is a healthcare hedge fund focusing on cannabinoid-based solutions and bio-pharmaceutical applications and therapies.
Todd learned his craft on the derivatives desk at Morgan Stanley, before moving on to Galleon Group, then becoming President and Head of Trading at Cramer Berkowitz. He discusses the early days of TheStreet.com, his relationship with Jim Cramer, and why 9/11 led to his interest in marijuana as a medical treatment.
He wrote the trading diary at TheStreet.com, and eventually launched investor education site Minyanville. Uniquely in the world of finance, the site won an Emmy for its Hoofy & Boo characters that made finance accessible to kids.
Harrison explains how cannabinoids are changing the face of health care and medicine; the pharmaceutical industry is in the early stages of “Buy/Build” of the medical marijuana industry. He notes that Bio-Pharmaceuticals — he does not invest in recreational weed — is the focus of his fund.
You can stream/download the full conversation, including the podcast extras on iTunes, Bloomberg, Overcast, and Stitcher. Our earlier podcasts can all be found on iTunes, Stitcher, Overcast, and Bloomberg.
Next week, we speak with Paul Vigna about Crypto and Blockchain, and author of The Age of Cryptocurrency: How Bitcoin and the Blockchain Are Challenging the Global Economic Order and this year’s The Truth Machine: The Blockchain and the Future of Everything.
Todd Harrison’s Book
Todd Harrison’s Favorite Books
Man’s Search for Meaning by Viktor Frankl
The Pot Book: A Complete Guide to Cannabis by Julie Holland M.D.